Asthma Drug Birth Defect Risk Seen When Used in Pregnancy: Study

A new study suggests a link between specific birth defects and asthma medication use during pregnancy, raising concerns about the safety of popular drugs like Advair and Symbicort among expectant mothers. 

According to a report published last week in the medical journal Pediatrics, research funded by the New York Center for Environmental Health found that the use of anti-imflammatory and bronchodilator drugs, alone or in combination, appeared to increase the risk of some rare birth defects by as much as 300% or more in some cases.

Researchers mined the National Birth Defects Prevention Study for data on 2,853 infants born with birth defects and 6,726 infants born without defects. Looking at cases where the mother was exposed to anti-inflammatory, bronchodilator asthma drugs or both, they found three specific types of rare birth defects that appeared to increase in prevalence. However, the researchers were unable to find any link between most common birth defects.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Women who used bronchodilators had more than double the risk of giving birth to a child with isolated esophageal atresia; a congenital birth defect where the esophagus fails to connect all the way to the stomach, requiring major surgery if the child is to survive. Women using anti-inflammatory asthma drugs during the first trimester had more than double the risk of giving birth to an infant with isolated anorectal atresia, in which the rectum or anus does not have a sufficient opening. For expecting mothers who took both types of asthma drugs combined, there was a more than 300% increased risk of giving birth to a child with omphalocele, an abdominal wall defect where some organs, including the intestines, liver and others, develop on the outside of the belly button.

Anti-inflammatory asthma drugs are typically inhaled corticosteroids like Flovent and Pulmicort. Brtonchodilators used for asthma include Albuterol and Combivent. The two types of drugs are used in combination in products including Advair and Symbicort.

The researchers found no association with other types of birth defects. They also noted that their findings could be due to numerical aberrations or that the birth defects could be caused by the severity of the mother’s asthma and related lack of oxygen to the developing fetus.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.